Prelude Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Prelude Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50,000	Closed	-$1.69M	–	2205
2021 Q2	$1.69M	Buy	+50,000	New	+$1.27M	0.05%	360

Prelude Capital Management's CNST Position: Q3 2021 in Review

Prelude Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 101,865 shares — an estimated $3.44M sold.

Prelude Capital Management first reported a position in CNST in Q1 2019 and held it in 3 quarters. The position peaked at $3.44M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Prelude Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Prelude Capital Management sold 101,865 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $3.44M.
Prelude Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2019 and held it in 3 quarters.
Prelude Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $3.44M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.